BioCep Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Out of Business

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

BioCep General Information

Description

Developer of an advanced cell separation technology platform designed to offer assistance for cell isolation processes. The company's platform yields large, pure and less damaged cell populations that can be applied in numerous medical processes, enabling researchers to develop advanced medicinal products that aids in immuno-magnetic cell isolation for research and development.

Contact Information

Website
www.biocep.com
Formerly Known As
InnovaTech
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 13A Einstein Street
  • Ness Ziona
  • Israel
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 13A Einstein Street
  • Ness Ziona
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioCep Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 15-Sep-2021 Completed Out of Business
5. Later Stage VC (Series A) 01-Feb-2014 Completed Generating Revenue
4. Later Stage VC 09-Jul-2013 Completed Generating Revenue
3. Secondary Transaction - Private 27-Aug-2012 Completed Generating Revenue
2. Early Stage VC 18-Jan-2011 $842K $842K Completed Generating Revenue
1. Grant 22-Jul-2010 $259K Completed Generating Revenue
To view BioCep’s complete valuation and funding history, request access »

BioCep Patents

BioCep Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D694423-S1 Disposable apparatus for cell separation Active 15-Dec-2011
AU-343259-S Disposable equipment for cell separation Inactive 15-Dec-2011
CA-146011-S Disposable equipment for cell separation Inactive 15-Dec-2011
AU-2011208382-A1 Magnetic separation of rare cells Active 21-Jan-2010
AU-2011208382-B2 Magnetic separation of rare cells Inactive 21-Jan-2010 C12N1/02
To view BioCep’s complete patent history, request access »

BioCep Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioCep Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Citrine S A L Funds Venture Capital Minority
To view BioCep’s complete investors history, request access »

BioCep FAQs

  • When was BioCep founded?

    BioCep was founded in 2006.

  • Where is BioCep headquartered?

    BioCep is headquartered in Ness Ziona, Israel.

  • What is the size of BioCep?

    BioCep has 5 total employees.

  • What industry is BioCep in?

    BioCep’s primary industry is Biotechnology.

  • Is BioCep a private or public company?

    BioCep is a Private company.

  • What is BioCep’s current revenue?

    The current revenue for BioCep is .

  • How much funding has BioCep raised over time?

    BioCep has raised $4.34M.

  • Who are BioCep’s investors?

    Citrine S A L Funds has invested in BioCep.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process